Clinical Trial Update: Chemo-embolization for Head and Neck Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial of chemo-embolization for head and neck squamous cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: SCCHN, Squamous Cell Carcinoma | Phase 2 | Status: WITHDRAWN